ArticleOncoTargets and therapy2022

Erratum: RANKL/RANK Pathway Abrogates Cetuximab Sensitivity in Gastric Cancer Cells via Activation of EGFR and c-Src [Corrigendum].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.